Beta-amyloid (Aβ) aggregates, an AD pathological hallmark, induce the NLRP3 pathway through TLR4 in the BV-2 microglia cell line, and its conditioned medium reduces HT-22 neuronal cell line viability [66]. This evidence concerns the gene NLRP3 and Alzheimer disease.